Skip to content

Algorithm Guided DBS Programming in Parkinson's Patients

Enhancing Deep Brain Stimulation Programming for Parkinson's Disease: A Semi- Automatic Algorithm-Guided Approach Using StimSearch- A Double Blind Randomized Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06205043
Enrollment
30
Registered
2024-01-12
Start date
2024-01-10
Completion date
2026-06-30
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Deep brain stimulation, Programming, Parkinson disease

Brief summary

Patients undergoing Deep Brain Stimulation for Parkinson's disease will be subjected to standard of care programming and compared with the algorithm based programming (StimSearch). Various parameters including the effectivity and efficiency of algorithm programming will be compared against the standard of care programming.

Detailed description

Patients of Parkinson's disease undergoing bilateral subthalamic nucleus stimulation (STN), we have already been adequately programmed and have achieved good outcome, will undergo an exploratory study to evaluate the effectiveness of algorithm based programming (Phase 1). Subsequently, patients undergoing STN DBS will be randomly allocated to algorithm based programming/ standard of care programming and after adequate stabilisation evaluated for motor improvement. They will be switched over to the alternative technique of programming and evaluated again after a similar period. Data regarding the time consumed, effectivity and several secondary endpoints will be evaluated.

Interventions

DEVICEStimSearch programming algorithm software

This is an algorithm based method to program deep brain stimulation in patients of Parkinson's disease

DEVICEClinician based programming

This is Standard of Care programming performed for patients undergoing deep brain stimulation for Parkinson's disease

Sponsors

Boston Scientific Corporation
CollaboratorINDUSTRY
Jaslok Hospital and Research Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Patients will be randomized to receive either an algorithm based program vs standard of care program. After a period each group will cross over to the other side. UPDRS assessments will be done at each time.

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Have a confirmed diagnosis of bilateral idiopathic Parkinson's disease * Exhibit a UPDRS subset III score of ≥ 25 while in the preoperative medication off state * Demonstrate an improvement of Parkinson's disease symptoms by ≥30% in the medication off state following a pre-operative levodopa challenge, as assessed by the UPDRS subset III score * Possess the ability to comprehend the study's demands, treatment protocols, and procedures, and provide written informed consent before undergoing any study-specific tests or procedures

Exclusion criteria

* Patients with notable psychiatric conditions, including unrelated clinically substantial depression as assessed by the investigator, will be excluded from participation.

Design outcomes

Primary

MeasureTime frameDescription
Comparison of efficacy between StimSearchTM-based programming and the best Standard of Care (SOC) based programming.4 weeksUnified Parkinson's disease rating scale scores (part III) will be used to evaluate this. Range (0-132) The lower the score indicates lesser severity of the disease and improved outcome.
Comparison of time required between StimSearch and SOC programming4 weeksTotal time in minutes will recorded

Secondary

MeasureTime frameDescription
Comparison of volume of tissue activated (VTA) between StimSearch and SOC4 weeksThe volume of tissue activated in cubic millimeter will be calculated.
Comparison of target volume between StimSearch and SOC4 weeksThe target volume in cubic millimeter will be calculated.

Countries

India

Contacts

Primary ContactParesh Doshi, MCh
pareshkd@gmail.com+91 9820063854

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026